Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
Active, not recruiting · NCT04850846 · Registry updated 2026-02-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, hematologic disorder, immune system disorder, immunoproliferative disorder, monoclonal gammopathy, monoclonal gammopathy of uncertain significance, neoplasm, precancerous condition, smoldering plasma cell myeloma | Active, not recruiting | Phase 2 | 2026-02-09 | NCT04850846 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| National Cancer Institute (NCI) | 3015 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 511 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Dana-Farber at Brighton | Brighton | United States | 1 |
| Dana-Farber at Merrimack Valley | Methuen | United States | 1 |
| Dana-Farber at Milford | Milford | United States | 4 |
| Dana-Farber at NHOH | Londonderry | United States | 1 |
| DF/ BWCC in Clinical Affiliation with South Shore Hospital | Weymouth | United States | 1 |